Home > Boards > US Listed > Medical - Healthcare > Mylan Inc. (MYL)

Drug price fixing, list of defendants,

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
JLS Member Profile
 
Followed By 59
Posts 7,123
Boards Moderated 0
Alias Born 12/14/04
160x600 placeholder
Medexus Appoints Accomplished Global Pharmaceutical Industry Executive Adele M. Gulfo to its Board of Directors GlobeNewswire Inc. - 6/25/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/21/2019 5:02:33 PM
Theravance Biopharma and Mylan Expand YUPELRI® (revefenacin) Development and Commercialization Agreement to Include China an... PR Newswire (US) - 6/14/2019 8:05:00 AM
Theravance Biopharma and Mylan Expand YUPELRI® (revefenacin) Development and Commercialization Agreement to Include China an... PR Newswire (US) - 6/14/2019 8:05:00 AM
Notice of Exempt Solicitation Pursuant to Rule 14a6(g) (px14a6n) Edgar (US Regulatory) - 6/13/2019 12:59:29 PM
Notice of Exempt Solicitation Pursuant to Rule 14a6(g) (px14a6n) Edgar (US Regulatory) - 6/7/2019 1:30:36 PM
Notice of Exempt Solicitation Pursuant to Rule 14a6(g) (px14a6n) Edgar (US Regulatory) - 5/31/2019 7:14:02 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 5/24/2019 5:13:35 PM
Theravance Biopharma and Mylan Present Additional YUPELRI® (revefenacin) Phase 3 Data Analysis at the 2019 ATS International... PR Newswire (US) - 5/20/2019 10:15:00 AM
Theravance Biopharma and Mylan Present Additional YUPELRI® (revefenacin) Phase 3 Data Analysis at the 2019 ATS International... PR Newswire (US) - 5/20/2019 10:15:00 AM
Mylan Presents Equivalence and Device Usability Data on Wixela™ Inhub™ Compared to Advair Diskus® at American Thoracic S... PR Newswire (US) - 5/18/2019 10:45:00 AM
Mylan to Host Investor Day on July 31, 2019 in New York City PR Newswire (US) - 5/17/2019 8:00:00 AM
Mylan and Biocon to Present Final Overall Survival Data for Ogivri™ (trastuzumab-dkst), a biosimilar to Herceptin®, at the... PR Newswire (US) - 5/15/2019 5:01:00 PM
Mylan Expands Oncology Portfolio with Launch of Generic Tarceva® Tablets PR Newswire (US) - 5/10/2019 9:45:00 AM
Mylan to Present at the 2019 Bank of America Merrill Lynch Healthcare Conference PR Newswire (US) - 5/10/2019 8:00:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 5/10/2019 6:08:13 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2019 11:07:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2019 8:37:17 AM
Mylan Reports First Quarter 2019 Results and Reaffirms 2019 Guidance PR Newswire (US) - 5/7/2019 8:30:00 AM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/30/2019 4:44:34 PM
Mylan to Release First Quarter 2019 Financial Results on May 7, 2019 PR Newswire (US) - 4/26/2019 7:30:00 AM
TB Alliance and Mylan Announce Global Collaboration to Commercialize Investigational Drug Pretomanid as Part of Two Regimens ... PR Newswire (US) - 4/18/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2019 6:02:46 PM
Striving to Create Better Health for a Better World: Mylan's Global Social Responsibility 2018 Progress Report Now Available PR Newswire (US) - 4/3/2019 11:00:00 AM
Mylan Institutional LLC Initiates Voluntary Nationwide Recall of Levoleucovorin Injection Due to the Presence of Particulate ... PR Newswire (US) - 3/18/2019 12:48:00 PM
JLS   Tuesday, 05/14/19 07:40:23 PM
Re: None
Post # of 141 
Drug price fixing, list of defendants,

ACTAVIS HOLDCO US, INC.
ACTAVIS PHARMA, INC.
AMNEAL PHARMACEUTICALS, INC.
APOTEX CORP.
ARA APRAHAMIAN
ARMANDO KELLUM
AUROBINDO PHARMA U.S.A ., INC.
BRECKENRIDGE PHARMACEUTICAL, INC.
DAVID BERTHOLD
DAVID REKENTHALER
DR. REDDY'S LABORATORIES, INC.
GLENMARK PHARMACEUTICALS, INC., USA
GREENSTONE LLC
JAMES (JIM) BROWN
JAMES (JIM) GRAUSO
JAMES (JIM) NESTA
JILL NAILOR
KEVIN GREEN
KONSTANTIN OSTAFICIUK
LANNETT COMPANY, INC.
LUPIN PHARMACEUTICALS, INC.
MARC FALKIN
MAUREEN CAVANAUGH
MYLAN PHARMACEUTICALS INC.
NISHA PATEL
PAR PHARMACEUTICAL COMPANIES, INC.
PFIZER, INC.
RICHARD (RICK) ROGERSON
SANDOZ, INC.
TARO PHARMACEUTICALS USA, INC.
TEVA PHARMACEUTICALS USA, INC.
TRACY SULLIVAN DIVALERIO
UPSHER-SMITH LABORATORIES, LLC
WOCKHARDT USA LLC
ZYDUS PHARMACEUTICALS (USA), INC.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist